Article

A Comprehensive Targeted Panel of 295 Genes: Unveiling Key Disease Initiating and Transformative Biomarkers in Multiple Myeloma

2023-11-01

Abstract excerpt

Multiple myeloma (MM) is a haematological cancer that evolves from the benign precursor stage termed monoclonal gammopathy of undetermined significance (MGUS). Understanding the pivotal biomarkers, genomic events, and gene interactions distinguishing MM from MGUS can significantly contribute to early detection and an improved understanding of MM’s pathogenesis. This study presents a curated, comprehensive, targete...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1e2bfd1d-12f2-5d56-901a-87a1c499a1ae
DOI: 10.1101/2023.10.28.564536

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Comprehensive Targeted Panel of 295 Genes: Unveiling Key Disease Initiating and Transformative Biomarkers in Multiple MyelomaDOI 10.1101/2023.10.28.564536Read

Individualized dynamic risk assessment for multiple myelomaSemantic proximity Read

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics.Semantic proximity Read

Exploring the Molecular Mechanisms and Shared Genetic Characteristics of Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaSemantic proximity Read

Genomic landscape of multiple myeloma and its precursor conditionsSemantic proximity Read

Mapping the Molecular Terrain of Multiple Myeloma: A Focus on Inflammation-Driven PathwaysSemantic proximity Read

Genomics Define Malignant Transformation in Myeloma Precursor ConditionsSemantic proximity Read

Genome-Wide Identification of Potential Biomarkers in Multiple Myeloma Using Meta-Analysis of mRNA and miRNA Expression DataSemantic proximity Read

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisSemantic proximity Read

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myelomaSemantic proximity Read

Genetic program activity delineates risk, relapse, and therapy responsiveness in Multiple MyelomaSemantic proximity Read

Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma.Semantic proximity Read